Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Intangibles: 2020-2024

Historic Intangibles for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $14.8 million.

  • Oncology Institute's Intangibles fell 2471.28% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year decrease of 2471.28%. This contributed to the annual value of $14.8 million for FY2024, which is 1728.11% down from last year.
  • Per Oncology Institute's latest filing, its Intangibles stood at $14.8 million for FY2024, which was down 1728.11% from $17.9 million recorded in FY2023.
  • Oncology Institute's Intangibles' 5-year high stood at $19.5 million during FY2020, with a 5-year trough of $14.8 million in FY2024.
  • Over the past 5 years, Oncology Institute's median Intangibles value was $18.0 million (recorded in 2022), while the average stood at $17.7 million.
  • Its Intangibles has fluctuated over the past 5 years, first fell by 29.51% in 2023, then tumbled by 1728.11% in 2024.
  • Annual analysis of 5 years shows Oncology Institute's Intangibles stood at $19.5 million in 2020, then fell by 6.51% to $18.2 million in 2021, then fell by 1.58% to $18.0 million in 2022, then dropped by 0.3% to $17.9 million in 2023, then dropped by 17.28% to $14.8 million in 2024.
  • Its last three reported values are $14.8 million in FY2024, $17.9 million for FY2023, and $18.0 million during FY2022.